FLT3 and acute myeloid leukemia: Crenolanib, an fms-related tyrosine kinase 3 (FLT3) inhibitor, increased FLT3 expression specifically in FLT3-ITD+ AML cell lines, and enhanced the antitumor activity of anti-FLT3 CAR T cells [255].